BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14704036)

  • 1. Molecular cytogenetic analyses of HIG, a novel human cell line carrying t(1;3)(p36.3;q25.3) established from a patient with chronic myelogenous leukemia in blastic crisis.
    Hosoya N; Ogawa S; Motokura T; Hangaishi A; Wang L; Qiao Y; Nannya Y; Kogi M; Hirai H
    Int J Hematol; 2003 Dec; 78(5):432-8. PubMed ID: 14704036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
    Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
    Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of t(3;3)(q21;q26.2) associated with severe multilineage dysplasia and multi-drug resistance in blastic crisis of chronic myelogenous leukemia].
    Lee SA; Lim J; Kim M; Kim Y; Han K
    Korean J Lab Med; 2010 Dec; 30(6):595-9. PubMed ID: 21157145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
    Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
    Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K
    Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.
    Hamaguchi H; Suzukawa K; Nagata K; Yamamoto K; Yagasaki F; Morishita K
    Br J Haematol; 1997 Aug; 98(2):399-407. PubMed ID: 9266939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia.
    Henzan H; Yoshimoto G; Okeda A; Nagasaki Y; Hirano G; Takase K; Tanimoto T; Miyamoto T; Fukuda T; Nagafuji K; Harada M
    Ann Hematol; 2004 Dec; 83(12):784-8. PubMed ID: 15322764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
    Asou H; Eguchi M; Suzukawa K; Morishita K; Tanaka K; Date M; Hamamoto K; Kamada N
    Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes.
    Raynaud SD; Baens M; Grosgeorge J; Rodgers K; Reid CD; Dainton M; Dyer M; Fuzibet JG; Gratecos N; Taillan B; Ayraud N; Marynen P
    Blood; 1996 Jul; 88(2):682-9. PubMed ID: 8695816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
    Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
    Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
    Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
    Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
    Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
    Xinh PT; Tri NK; Nagao H; Nakazato H; Taketazu F; Fujisawa S; Yagasaki F; Chen YZ; Hayashi Y; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2003 Mar; 36(3):313-6. PubMed ID: 12557231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).
    Jarmuz M; Kroll R; Przybyłowicz-Chalecka A; Ratajczak B; Gniot M; Szyfter K; Komarnicki M
    Cancer Genet Cytogenet; 2010 May; 199(1):45-7. PubMed ID: 20417868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. t(3;14)(q26;q11) associated with megakaryoblastic transformation of chronic myeloid leukemia.
    de la Chica RA; Pueyo JM; Matilla A; Labraña X; Padron F; Guerras L; Sole F; Plaja A
    Cancer Genet Cytogenet; 1991 Aug; 55(1):133-4. PubMed ID: 1913601
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
    Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
    Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).
    Shimizu S; Suzukawa K; Kodera T; Nagasawa T; Abe T; Taniwaki M; Yagasaki F; Tanaka H; Fujisawa S; Johansson B; Ahlgren T; Yokota J; Morishita K
    Genes Chromosomes Cancer; 2000 Mar; 27(3):229-38. PubMed ID: 10679911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
    Suzukawa K; Taki T; Abe T; Asoh H; Kamada N; Yokota J; Morishita K
    Genomics; 1997 Jun; 42(2):356-60. PubMed ID: 9192861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.